Moderna
MRNA
#1332
Rank
S$17.71 B
Marketcap
$45.83
Share price
-2.03%
Change (1 day)
-67.69%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

EPS for Moderna (MRNA)

EPS in 2023 (TTM): -$12.56

According to Moderna 's latest financial reports the company's current EPS (TTM) is -$12.21. In 2022 the company made an earnings per share (EPS) of $28.22 a decrease over its 2021 EPS that were of $40.46.

EPS history for Moderna from 2018 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$12.56-144.49%
2022$28.22-30.25%
2021$40.46-1660.82%
2020-$2.5925.16%
2019-$2.0737.04%
2018-$1.51

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$2.26-81.51%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.43-119.93%๐Ÿ‡บ๐Ÿ‡ธ USA
-$4.05-66.85%๐Ÿ‡บ๐Ÿ‡ธ USA
-$5.49-55.03%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.00-140.92%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
-$2.27-81.40%๐Ÿ‡บ๐Ÿ‡ธ USA
$18.82-254.11%๐Ÿ‡บ๐Ÿ‡ธ USA